fondazione per la ricerca farmacologica
gianni benzi onlus
Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus is a Scientific Research Organisation, registered as a private, not-for-profit Foundation in 2007, with the aim to promote research in biological, medical and pharmaceutical areas in support of the development of innovative and safe medicines in Europe.
Discover more about us through this video.
HIGHLIGHTS
Delve into some of the most important activities now running at Fondazione Gianni Benzi
XVI Foresight Training Course (18 December 2023)
Newsletter no. 22 - September 2023
New article published: Off-label is not always off-evidence: authorising paediatric indications for old medicines
Training & Education
Keep updated on all the initiatives and events of the Gianni Benzi Onlus Foundation dedicated to the comparison of research and training topics.
SAVE THE DATE – Meeting on Sickle Cell Disease: new challenges and perspectives in Italy (Rome, 20 November 2023)
The meeting “La Malattia Drepanocitica – nuove sfide e prospettive in Italia con le raccomandazioni della Commission di Lancet Haematology” will be held in Rome on 20 November 2023 at Sala Zuccari, Palazzo Giustiniani.
SAVE THE DATE – XVI Foresight Training Course: 18 December 2023, Bari – Italy
Fondazione Gianni Benzi, in collaboration with Università degli Studi di Bari Aldo Moro, organises the XVI Foresight Training Course “Repurposing to cover unmet needs: the current scenario in Europe and the proposed changes to the Pharmaceutical Legislation”.
New article on paediatric chronic pain
Professor Adriana Ceci from Fondazione Gianni Benzi, cooperated as co-author to the article “Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain” just published in the Pharmacology Research & Perspectives journal.
EJP RD: MOOC From Lab to Clinic: Translational Research for Rare Diseases
The French Foundation for Rare Diseases has announced the opening of a new facilitation window of the Massive Open Online Course – MOOC From Lab to Clinic: Translational Research for Rare Diseases on October 9th